Detalles de la búsqueda
1.
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
Am J Gastroenterol;
118(7): 1184-1195, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940437
2.
REAP-HP survey 2020: Comparing the real-world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020.
Helicobacter;
27(6): e12931, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161426
3.
Fourteen-day sequential therapy is superior to 7-day triple therapy as first-line regimen for Helicobacter pylori infected children.
J Formos Med Assoc;
121(1 Pt 1): 202-209, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33745813
4.
Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience.
Dig Dis Sci;
63(2): 437-445, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29264696
5.
Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).
Helicobacter;
22(3)2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28244264
6.
The C-terminal disulfide bonds of Helicobacter pylori GroES are critical for IL-8 secretion via the TLR4-dependent pathway in gastric epithelial cells.
J Immunol;
194(8): 3997-4007, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769921
7.
High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection.
Clin Gastroenterol Hepatol;
13(5): 895-905.e5, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460556
8.
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection.
Microorganisms;
12(1)2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38276175
9.
Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.
Oncologist;
17(5): 732-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22511265
10.
Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin.
Evid Based Complement Alternat Med;
2012: 127043, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23227093
11.
Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel.
Biopharm Drug Dispos;
33(5): 278-83, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623337
12.
Identification of 14-3-3ß in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
Proteomics;
11(12): 2423-39, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21598387
13.
Silicon-containing water intake confers antioxidant effect, gastrointestinal protection, and gut microbiota modulation in the rodents.
PLoS One;
16(3): e0248508, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33788857
14.
Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of Helicobacter pylori.
ACS Appl Mater Interfaces;
12(49): 54316-54327, 2020 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33236884
15.
Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis.
BMJ Open Gastroenterol;
7(1)2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32883715
16.
Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori.
BMC Microbiol;
9: 136, 2009 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19594901
17.
Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori.
Br J Clin Pharmacol;
67(5): 503-10, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19552744
18.
A rare cause of obstructive jaundice.
Clin Gastroenterol Hepatol;
11(7): A31, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23200985
19.
Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.
J Nutr;
138(11): 2084-90, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18936202
20.
Change of Uncertainty in Illness and Unmet Care Needs in Patients With Recurrent Hepatocellular Carcinoma During Active Treatment.
Cancer Nurs;
41(4): 279-289, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28410334